F14 INCDNT-RLS
NDC 63479-0614, ARNICA MONTANA, ARNICA MONTANA, CALOCHORTUS GUNNISONII, CHERRY PLUM, CLEMATIS VITALBA, DICENTRA FORMOSA, EHRENDORFERIA CHRYSANTHA, ENGLISH HAWTHRON, HYPERICUM PERFORATUM, IGNATIA AMARA, IMPATIENS GLANDULIFERA, ORNITHOGALUM UMBELLATUM, PRUNELLA VULGARIS, ROCKROSE, RUTA GRAVEOLENS, STAPHYSAGRIA, solution/ drops, from Apex Energetics Inc..
- Product NDC
- 63479-0614
- Status
- Listed
- Labeler
- Apex Energetics Inc.
- Dosage form
- SOLUTION/ DROPS
- Route
- SUBLINGUAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63479-0614 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CLEMATIS VITALBA FLOWER12 [hp_C]/mL
- DICENTRA FORMOSA WHOLE12 [hp_C]/mL
- CRATAEGUS MONOGYNA FLOWER12 [hp_C]/mL
- EHRENDORFERIA CHRYSANTHA WHOLE12 [hp_C]/mL
- HELIANTHEMUM NUMMULARIUM FLOWER12 [hp_C]/mL
- RUTA GRAVEOLENS FLOWERING TOP15 [hp_X]/mL
- ARNICA MONTANA30 [hp_X]/mL
- ARNICA MONTANA FLOWER12 [hp_C]/mL
- PRUNUS CERASIFERA FLOWER12 [hp_C]/mL
- HYPERICUM PERFORATUM FLOWER12 [hp_C]/mL
- HYPERICUM PERFORATUM20 [hp_X]/mL
- PRUNELLA VULGARIS FLOWER12 [hp_C]/mL
- CALOCHORTUS GUNNISONII WHOLE12 [hp_C]/mL
- STRYCHNOS IGNATII SEED15 [hp_C]/mL
- IMPATIENS GLANDULIFERA FLOWER12 [hp_C]/mL
- ORNITHOGALUM UMBELLATUM FLOWERING TOP12 [hp_C]/mL
- DELPHINIUM STAPHISAGRIA SEED12 [hp_C]/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63479-0614-1 | 63479061401 | 30 mL in 1 BOTTLE, GLASS (63479-0614-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 63479-0614 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63479-0614 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63479-0614. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.